Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248M Sell
1,274,897
-75,337
-6% -$15.6M 0.21% 82
2026
Q1
$303M Buy
1,350,234
+247,758
+22% +$61.7M 0.32% 67
2025
Q4
$266M Buy
1,102,476
+559,765
+103% +$143M 0.26% 86
2025
Q3
$149M Buy
542,711
+109,760
+25% +$30M 0.15% 115
2025
Q2
$112M Buy
432,951
+35,632
+9% +$8.5M 0.13% 135
2025
Q1
$88.9M Buy
397,319
+324,428
+445% +$75.7M 0.12% 148
2024
Q4
$16.7M Buy
72,891
+601
+0.8% +$145K 0.02% 384
2024
Q3
$17.6M Sell
72,290
-94
-0.1% -$21K 0.02% 373
2024
Q2
$13.9M Buy
72,384
+4,162
+6% +$844K 0.02% 386
2024
Q1
$13.5M Buy
68,222
+761
+1% +$139K 0.12% 263
2023
Q4
$11.6M Sell
67,461
-199
-0.3% -$30.6K 0.02% 404
2023
Q3
$10M Buy
67,660
+824
+1% +$149K 0.02% 410
2023
Q2
$14.6M Buy
66,836
+21
+0% +$4.68K 0.02% 363
2023
Q1
$14.6M Sell
66,815
-1,720
-3% -$373K 0.03% 359
2022
Q4
$14.3M Sell
68,535
-14,811
-18% -$3.25M 0.03% 367
2022
Q3
$18.2M Sell
83,346
-638
-0.8% -$145K 0.04% 318
2022
Q2
$17.6M Sell
83,984
-26
-0% -$5.54K 0.04% 318
2022
Q1
$20.4M Sell
84,010
-641
-0.8% -$155K 0.04% 325
2021
Q4
$22.2M Sell
84,651
-16,483
-16% -$4.28M 0.04% 328
2021
Q3
$26.7M Sell
101,134
-4,599
-4% -$1.26M 0.05% 282
2021
Q2
$26.1M Sell
105,733
-196
-0.2% -$41.2K 0.05% 295
2021
Q1
$20.6M Buy
+105,929
New +$21.2M 0.04% 324

Other funds holding RMD

Swedbank's RMD Position: Q2 2026 in Review

Swedbank reduced its ResMed (RMD) stake by 5.6% in Q2 2026, selling an estimated $15.6M and leaving 1,274,897 shares worth $248M. The position accounts for 0.21% of the portfolio, ranked #82.

Swedbank first reported a position in RMD in Q1 2021 and has held it in 22 quarters since. The position peaked at $303M in Q1 2026. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Swedbank held 1,274,897 shares of ResMed worth $248M as of Q2 2026.
  • Swedbank sold 75,337 ResMed shares in Q2 2026, an estimated $15.6M.
  • ResMed made up 0.21% of Swedbank's portfolio in Q2 2026, its #82 holding.
  • Swedbank first reported a position in ResMed in Q1 2021 and has held it in 22 quarters since.
  • Swedbank's ResMed position peaked at $303M in Q1 2026.
  • 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.